The RSC CNN Early Career Researcher Virtual Poster Meeting will be free to attend.
We will have a plenary talk by Dr. Nazende G眉nday-T眉reli, Head of R&D Pharma at MyBiotech GmbH who will discuss "Nanopharmaceuticals: hard road to Good manufacturing Practice"
This will be followed by virtual poster sessions for attendees. Sessions will be grouped into the following fields: Energy, Health, Environmental, Synthesis & Characterisation, Techniques, Industry & Tech Transfer.
Poster prizes will be awarded in each of the six areas.
Registration and abstract submission will begin on on Monday 9th May
Deadline for abstract submission will be Friday 3rd June
Plenary speaker
Dr. Nazende G眉nday T眉reli is an acknowledged scientific manager with over 15 years of R&D experience at leading positions of international pharmaceutical companies and contract research organisations. Her experience covers a wide range of areas including Quality-by-Design (QbD) approaches on pharmaceutical nano(bio)technology, quality management systems and project management. She has extensive GMP operations knowledge, as well as solid know-how on innovative nano drug delivery systems. She is the winner of the 2014 Global CPhI Pharma Awards for Best Innovation in Formulation category. She served as the industry representative of the Controlled Release Society (CRS) Focus Group Nanomedicine and Nanoscale Delivery (NND). She holds a Doctorate in Biopharmaceutics and Pharmaceutical Technology from the University of Saarland, Germany. She has already coordinated and participated in various national and international projects as principal investigator, yielding more than 8M 鈧� funding for her research projects over the last 5 years.
We will have a plenary talk by Dr. Nazende G眉nday-T眉reli, Head of R&D Pharma at MyBiotech GmbH who will discuss "Nanopharmaceuticals: hard road to Good manufacturing Practice"
This will be followed by virtual poster sessions for attendees. Sessions will be grouped into the following fields: Energy, Health, Environmental, Synthesis & Characterisation, Techniques, Industry & Tech Transfer.
Poster prizes will be awarded in each of the six areas.
Registration and abstract submission will begin on on Monday 9th May
Deadline for abstract submission will be Friday 3rd June
Plenary speaker
Dr. Nazende G眉nday T眉reli is an acknowledged scientific manager with over 15 years of R&D experience at leading positions of international pharmaceutical companies and contract research organisations. Her experience covers a wide range of areas including Quality-by-Design (QbD) approaches on pharmaceutical nano(bio)technology, quality management systems and project management. She has extensive GMP operations knowledge, as well as solid know-how on innovative nano drug delivery systems. She is the winner of the 2014 Global CPhI Pharma Awards for Best Innovation in Formulation category. She served as the industry representative of the Controlled Release Society (CRS) Focus Group Nanomedicine and Nanoscale Delivery (NND). She holds a Doctorate in Biopharmaceutics and Pharmaceutical Technology from the University of Saarland, Germany. She has already coordinated and participated in various national and international projects as principal investigator, yielding more than 8M 鈧� funding for her research projects over the last 5 years.
